Stay updated on Rebastinib with Paclitaxel in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.3 in the page footer, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T14:40:54.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and Revision: v3.4.1 removed, reflecting a maintenance update on the site. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T09:27:17.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A general site notice about a lapse in government funding and NIH operating status was added, directing users to cc.nih.gov and opm.gov for updates. The site revision version was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T06:23:13.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and new metadata items 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Removed the previous metadata items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T04:07:40.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:07:44.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Locations information has been reorganized into a single Locations section listing all participating states (Alabama, Colorado, Illinois, Kansas, Massachusetts, New York, Ohio, Oklahoma, Pennsylvania, Rhode Island, Tennessee, Texas), replacing the prior per-state location blocks.
    Difference
    1%
    Check dated 2025-12-23T17:33:33.000Z thumbnail image

Stay in the know with updates to Rebastinib with Paclitaxel in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page.